Skip to content
  • Tuesday, 29 September 2026
  • 11:30 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Novo Nordisk Secures $1.33bn Nanexa Licensing Deal to Accelerate Long-Acting Cardiometabolic Therapies
Pharmaceutical R&D

Novo Nordisk Secures $1.33bn Nanexa Licensing Deal to Accelerate Long-Acting Cardiometabolic Therapies

Teuku Ryan Sep 29, 2026 0

The global pharmaceutical landscape is undergoing a profound structural evolution, driven by surging demand for treatments addressing obesity, type 2…

Read More
Stem Cell & Regenerative Medicine

Cornell University Breakthrough Marks Significant Advance Toward Long-Acting Nonhormonal Male Contraceptive

Dwi Wanna Jul 20, 2026 0

In a landmark development for reproductive medicine, researchers at Cornell University have identified a biological pathway that could lead to…

Read More
Environmental & Analytical Chemistry

Short-acting methods matched long-acting options in a contraceptive initiative that centered users

Abdurrohim Arsyad Jul 10, 2026 0

A groundbreaking contraceptive initiative in Salt Lake City has revealed that when individuals are empowered to choose their preferred birth…

Read More
Stem Cell & Regenerative Medicine

Cornell University Scientists Identify Breakthrough Nonhormonal Path Toward Reversible Long Acting Male Contraception.

Dwi Wanna Jun 13, 2026 0

In a landmark advancement for reproductive science, researchers at Cornell University have announced a significant breakthrough in the quest for…

Read More
Stem Cell & Regenerative Medicine

Cornell University scientists develop a safe reversible and long-acting nonhormonal male contraceptive through targeted meiotic disruption

Dwi Wanna Apr 30, 2026 0

Researchers at Cornell University have announced a significant breakthrough in reproductive science, successfully demonstrating a method for nonhormonal male contraception…

Read More
This breakthrough could finally unlock male birth controlReal-Time Observation of Metal-Induced Protein Clumping Offers New Pathways for Alzheimer’s Treatment StrategiesJovian Moons May Have Received Life’s Chemical Building Blocks During FormationNature-Inspired Structural Whiteness Technique Eliminates Titanium Dioxide and PFAS in Next-Generation Materials
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must Have
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research StudyMolten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low TemperaturesDaiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA DiscussionsScience News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
Dual-Drug Therapy Breakthrough Offers New Hope for Acute Myelogenous Leukemia Patients in Landmark Ludwig Cancer Research Study
Dwi Wanna Sep 29, 2026
Advanced Materials Science
Molten Salt Breakthrough: Oak Ridge Researchers Convert Common Plastic Waste Into Gasoline and Diesel at Low Temperatures
Nila Kartika Wati Sep 29, 2026
Pharmaceutical R&D
Daiichi Sankyo and Merck Voluntarily Withdraw US Application for Lung Cancer Drug Ifinatamab Deruxtecan Following FDA Discussions
Teuku Ryan Sep 29, 2026
Environmental & Analytical Chemistry
Science News: A Century of Independent Scientific Journalism and the Evolution of Public Literacy
Abdurrohim Arsyad Sep 29, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ